Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.
Clinical and Experimental Medicine · 2024
DOI: 10.1007/s10238-024-01311-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Celine Man Ying Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Surgery, Adelaide Medical School, The University of Adelaide, Adelaide, SA, 5005, Australia. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Adelaide, Cancer Council SA Beat Cancer, The Hospital Research Foundation Group.
Abstract (Originalsprache)
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. CRC liver metastases (CRLM) are often resistant to conventional treatments, with high rates of recurrence. Therefore, it is crucial to identify biomarkers for CRLM patients that predict cancer progression. This study utilised matrix-assisted laser desorption/ionisation mass spectrometry imaging (MALDI-MSI) in combination with liquid chromatography-tandem mass spectrometry (LC-MS/MS) to spatially map the CRLM tumour proteome. CRLM tissue microarrays (TMAs) of 84 patients were analysed using tryptic peptide MALDI-MSI to spatially monitor peptide abundances across CRLM tissues. Abundance of peptides was compared between tumour vs stroma, male vs female and across three groups of patients based on overall survival (0-3 years, 4-6 years, and 7+ years). Peptides were then characterised and matched using LC-MS/MS. A total of 471 potential peptides were identified by MALDI-MSI. Our results show that two unidentified m/z values (1589.876 and 1092.727) had significantly higher intensities in tumours compared to stroma. Ten m/z values were identified to have correlation with biological sex. Survival analysis identified three peptides (Histone H4, Haemoglobin subunit alpha, and Inosine-5’-monophosphate dehydrogenase 2) and two unidentified m/z values (1305.840 and 1661.060) that were significantly higher in patients with shorter survival (0-3 years relative to 4-6 years and 7+ years). This is the first study using MALDI-MSI, combined with LC-MS/MS, on a large cohort of CRLM patients to identify the spatial proteome in this malignancy. Further, we identify several protein candidates that may be suitable for drug targeting or for future prognostic biomarker development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Surgery, Adelaide Medical School, The University of Adelaide, Adelaide, SA, 5005, Australia.
- The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Adelaide, SA, 5011, Australia.
- Clinical and Health Sciences, University of South Australia, Adelaide, SA, 5000, Australia.
- SA Pathology, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia.
- Institute for Research in Molecular Medicine, University Sains Malaysia, 11800, Pulau Pinang, Malaysia.
- Clinical and Health Sciences, University of South Australia, Adelaide, SA, 5000, Australia. manuela.klingler-hoffmann@unisa.edu.au.
Förderung
- University of Adelaide
- Cancer Council SA Beat Cancer
- The Hospital Research Foundation Group
- Bioplatforms Australia
- The University of Adelaide
Zitieren
APA
Li, C. M. Y., Briggs, M. T., Lee, Y. R., Tin, T., Young, C., Pierides, J., Kaur, G., Drew, P., Maddern, G. J., Hoffmann, P., Klingler-Hoffmann, M., & Fenix, K. (2024). Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01311-5
Vancouver
Li CMY, Briggs MT, Lee YR, Tin T, Young C, Pierides J, et al. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01311-5
BibTeX
@article{Li2024,
author = {Li, Celine Man Ying and Briggs, Matthew T and Lee, Yea-Rin and Tin, Teresa and Young, Clifford and Pierides, John and Kaur, Gurjeet and Drew, Paul and Maddern, Guy J and Hoffmann, Peter and Klingler-Hoffmann, Manuela and Fenix, Kevin},
title = {Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases},
journal = {Clinical and Experimental Medicine},
year = {2024},
doi = {10.1007/s10238-024-01311-5}
}
EUVIMED